XML 14 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 51,058 $ 88,003
Accounts receivable, net 0 69
Prepaid expenses and other current assets 1,058 1,114
Total current assets 52,116 89,186
Property and equipment, net 493 624
Employee loans receivable - related party 3 49
Other long-term assets 2,103 1,673
Total assets 54,715 91,532
Current liabilities:    
Accounts payable and accrued expenses 10,156 6,627
Accounts payable and accrued expenses - related party 406 880
Deferred revenue 21 219
Total current liabilities 10,583 7,726
Other liabilities 225 245
Total liabilities 10,808 7,971
Commitments and contingencies
Redeemable noncontrolling interest 155,147 161,531
Stockholders’ deficit:    
Additional paid-in capital 122,838 117,686
Accumulated deficit (234,407) (195,985)
Total stockholders’ deficit attributable to vTv Therapeutics Inc. (111,240) (77,970)
Total liabilities, redeemable noncontrolling interest and stockholders’ deficit 54,715 91,532
Class A Common Stock [Member]    
Stockholders’ deficit:    
Common stock value 97 92
Total stockholders’ deficit attributable to vTv Therapeutics Inc. 97 92
Class B Common Stock [Member]    
Stockholders’ deficit:    
Common stock value 232 237
Total stockholders’ deficit attributable to vTv Therapeutics Inc. $ 232 $ 237